MANGALAM DRUGS & ORGANICS Q3 FY25 Results

MANGALAM DRUGS & ORGANICS has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 88.71 Cr
• Quarter-on-Quarter (QoQ) Change: 10.97% (Previous Quarter: Rs. 79.94 Cr )
• Year-on-Year (YoY) Change: -8.86% (Same Quarter Last Year: Rs. 97.34 Cr )

Profitability Metrics

• Net Profit: Rs. 1.29 Cr
• QoQ Profit Change: -52.16% (Previous Quarter: Rs. 2.69 Cr )
• YoY Profit Change: 158.45% (Same Quarter Last Year: Rs. 0.50 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 0.81
• QoQ EPS Change: -52.35% (Previous Quarter: Rs. 1.70)
• YoY EPS Change: 161.29% (Same Quarter Last Year: Rs. 0.31)

Performance Summary

Mixed

MANGALAM DRUGS & ORGANICS had a complex financial situation. Different parts of the business are performing differently, showing a changing market.

This analysis provides a snapshot of MANGALAM DRUGS & ORGANICS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.